TET2 and breast cancer: As expected based on the analysis described above (Fig. 1), only ASXL1 was mutated in CP at a frequency comparable to that in BC, while other mutations, including TET2, KMT2D, PTPN11, RUNX1, and WT1, were found at much lower frequencies compared to those in BC (Fig. 6a, b, Supplementary Table 6, and Supplementary Data 2).